Topic

Drugs on tap- the hidden enivronmental impact of prescription drugs

Christelle Blunden
Christelle Blunden • 27 February 2012

Comments (2)

Rachel Stancliffe
Rachel Stancliffe

Hi Christelle

There is no decent (or indecent!) comparative data that we have found but it is much needed. The SDU had a meeting with some pharma companies last autumn to get them on board with starting such a project and has recently asked for tenders for a project to set standards and metrics for pharma footprinting - see  http://www.sdu.nhs.uk/news-events/news/160/Tenders-required-for-experts-in-footprinting-pharmaceuticals-and-medical-devices-  We should know soon who will carry out the project. I have the details for the tender if anyone wants me to send it to them - or I can ask SDU if we can post on here. 

We (CSH) will be doing some comparative work of different interventions (might be drug A vs drug B or might be drug vs alternative) as part of our Sustainable Specialty Programmes - starting with respiratory (COPD) in the next couple of months so we will let you know when we get started on that.  

If anyone has any expertise in this area, or does know of any existing research, it would be great to link up! I'll report back as I learn more...


Please log in or sign up to comment.